Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CANCER EXAMINATION METHOD AND CANCER TREATMENT AGENT
Document Type and Number:
WIPO Patent Application WO/2022/114091
Kind Code:
A1
Abstract:
The present invention relates to a method for predicting the prognosis of patients with lung adenocarcinoma. The present invention relates to a method for predicting the prognosis after cancer removal of patients with lung adenocarcinoma. The present invention also relates to a method for treating patients with lung adenocarcinoma.

Inventors:
OYAMA TSUNEHIRO (JP)
Application Number:
PCT/JP2021/043304
Publication Date:
June 02, 2022
Filing Date:
November 26, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
IMAMITSUKAI MEDICAL CORP (JP)
International Classes:
A61K45/00; A61P11/00; A61P35/00; A61P43/00; C12Q1/686; G01N33/68
Domestic Patent References:
WO2013132001A12013-09-12
WO2009117367A12009-09-24
Foreign References:
US20140271474A12014-09-18
JP2007520996A2007-08-02
JP2012525845A2012-10-25
Other References:
WANG JINLU, JI HONGFEI, NIU XINGJIAN, YIN LEI, WANG YIRAN, GU YUCUI, LI DONGBO, ZHANG HAN, LU MINGHUI, ZHANG FENGXIA, ZHANG QINGYU: "Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer", DISEASE MARKERS, vol. 2020, 21 April 2020 (2020-04-21), GB , pages 1 - 12, XP055934072, ISSN: 0278-0240, DOI: 10.1155/2020/6103542
MARCO PEREZ, JUAN M. PRAENA-FERNANDEZ, BLANCA FELIPE-ABRIO, MARIA A. LOPEZ-GARCIA, ANTONIO LUCENA-CACACE, ANGEL GARCIA, MATILDE LL: "MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival", PLOS ONE, vol. 8, no. 2, 1 January 2013 (2013-01-01), US , pages 1 - 10, XP055060310, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0056169
Attorney, Agent or Firm:
UMEDA Shinsuke et al. (JP)
Download PDF:



 
Previous Patent: WIRE HARNESS

Next Patent: TRANSMISSION LINE AND ELECTRONIC DEVICE